P1008 Subcutaneous Infliximab in IBD Patients Previously Treated with an Optimized Intravenous Infliximab Dosing Schedule: Preliminary Results on Expectations and Satisfaction of Switching from Intravenous to Subcutaneous Infliximab
Journal of Crohn's and Colitis(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要